• 1 Vote(s) - 5 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Hepatitis C drugs help combat Covid-19 in trials
#1
As per Financial Times on 8th July, it has been said that a combination of antiviral drugs have shown promising results in treating Covid-19 in Iran. In results from three trials, 94 per cent of hospitalised patients taking a combination of sofosbuvir and daclatasvir showed reduced fevers and improved breathing versus 70 per cent in the control arm.
Like   Reply
#2
I have been hearing new medicines and new drugs being effective in trials every week now. If they can sustain such a high level of success (94%), then this might be great news to us . Both otherwise, I am still largely skeptical whether these drugs will have any effect or not.
Like   Reply
#3
(07-10-2020, 03:56 AM)SamYu Wrote: I have been hearing new medicines and new drugs being effective in trials every week now. If they can sustain such a high level of success (94%), then this might be great news to us . Both otherwise, I am still largely skeptical whether these drugs will have any effect or not.

Yea i agree with you with this. Weren't cheap steroid effective last week too? Their news was literally everywhere and now suddenly I have stopped seeing them? Was their effectiveness a coincidence?
Like   Reply
#4
(07-10-2020, 03:56 AM)SamYu Wrote: I have been hearing new medicines and new drugs being effective in trials every week now. If they can sustain such a high level of success (94%), then this might be great news to us . Both otherwise, I am still largely skeptical whether these drugs will have any effect or not.
Hydroxychloroquine was also supposedly promising but it didnt go anywhere. All these drugs seem to tell the same story.
Like   Reply
#5
(07-11-2020, 11:02 AM)Shreya6 Wrote:
(07-10-2020, 03:56 AM)SamYu Wrote: I have been hearing new medicines and new drugs being effective in trials every week now. If they can sustain such a high level of success (94%), then this might be great news to us . Both otherwise, I am still largely skeptical whether these drugs will have any effect or not.
Hydroxychloroquine was also supposedly promising but it didnt go anywhere. All these drugs seem to tell the same story.

Remdesivir, a drug which America has paid to capture 90% of its production, might cost around $3000 a dose. That's after insurance. How can the middle-class afford that with an uncertainty in its success rate? In fact, they could sell the drug at $10 a dose and still make a profit.
Like   Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)